Overview Live Pharmaceutical Webinars and Webinar Recordings
Next Live Webinars
Rethinking the development of controlled release formulations and manufacturing processes
Rethinking the development of controlled release formulations and manufacturing processes
- The different types of controlled release formulations
- How the formulations are currently manufactured
- The benefits of controlled-release formulations
- Case studies and prototypes of standard vs specialized solutions
Date & Time & Timezone: Apr 30, 2024 03:00 PM in Amsterdam, Berlin, Rom, Stockholm, Wien
Speaker:
Ketaki Patwardhan
Global Technical Developer, Roquette
Talles Ernica
Global Technical Developer, Roquette
- Pharma R&D, as oral dosage forms, topics, injectables, ANDA and NDA products.
- Process and production, such as troubleshooting, scale-up/down, improvement, and equipment implementation.
- Technical customer support as an excipient and ingredient supplier
- Roquette team member, Global Technical Developer since 2012
For more information & registration:
Rational Selection of Cyclodextrins for the Solubilization of Poorly Soluble Oral Drugs
Development of directly compressible formulations of Sitagliptin hydrochloride and Sitagliptin phosphate.
Antioxidants, a safe and viable Inhibition Strategy for Nitrosamine Formation In Drug Products
Rational Selection and Application of Ready-to-Use Formulations for Self-Emulsifying Drug Delivery Systems
Glatt: Pellets from fluid bed processes – a smart concept for high(er) potent drug processing
Glatt: Quality Services along the Value Chain
From powder to DC oral solid dosage form – using galenIQ™, the sweet-tasting filler binder.
Solving one of the biggest limitations of modern clinical trials: Patient Recruitment
Downstream Processing with Alexanderwerk & Shin-Etsu
Spray drying with Shin-Etsu, ProCepT and Xedev
Multiparticulates Part 8: Scale up considerations on the Wurster (bottomspray) fluidized bed process
Hot Melt Extrusion (HME) with Shin-Etsu, Leistritz and the St. John’s University
Make it Right: Best Practices for mRNA Manufacturing
Regulatory Considerations Regarding Immediate Release Film Coatings Post-Approval Changes in the U.S and Europe
Multiparticulates 7 – Next Generation ODTS with high dosed Multiparticulates
ZoomLab™: Digitally guiding dosage form and formulation for improved solubility
Multiparticulates – modern oral drug products for our society; Part 6: DoE case studies in QbD development
Don’t Feed the Trolls – Crazy Powders and Electrostatic Charge in Continuous Manufacturing
Multiparticulates 5 – Product and process development applying QbD and DoE concepts to define DS
galenIQ™ – Ask the expert!
Addressing Raw Material Handling Challenges by Dry Granulation
Rx & OTC Product Line Extensions with Oral Lipid-Based Delivery Platforms
Merck: 3D Printing – shaping the future of formulation development
Multiparticulates 4b – Glatt Fluidbed Wurster Drug Layering and Coating – the Process
ZoomLab™ – The interview with Dr. Ferdinand Brandl from BASF
Multiparticulates Part IVa: Functional Coating Applications – The Basics
Understanding the regulatory landscape of Titanium Dioxide, and the impact on tablet film coatings that are Ti02 free
Ready-to-Use: When Film Coating Becomes Easy, Fast & Reliable
BASF & Catalent: Optimizing Lipid-Based Formulation For Commercial Success
Multiparticulates for paediatric oral drug delivery
Neutral And Functional Starter Pellets
DiCOM SANAQ® – a move forward into direct compression
The Easy Way Of Tableting: Excipient Premixes For Direct Compression
Multiparticulates From Matric Core Pellets – Glatt CPS® Technology
Market Trends & Clean Label Solutions for Solid Oral Dosage Forms
Multiparticulates As Modern Oral Drug Products
Multiparticulates Part III: Multiparticulates From Matrix Core Pellets – Glatt MicroPx And ProCell Technology
Leveraging Digital Assistance to Address Oral Solid Dosage Formulation Challenges
Innovative Technologies For Amorphous Solid Dispersions
A beginners guide to SELF’ies for solubility and oral bioavailability enhancement
Key to Successful Formulation Development for Lipid Based RNA Delivery and Vaccines